Belyaeva Olga V, Korkina Olga V, Stetsenko Anton V, Kim Tom, Nelson Peter S, Kedishvili Natalia Y
Department of Biochemistry and Molecular Genetics, Schools of Medicine and Dentistry, University of Alabama at Birmingham, 35294, USA.
Biochemistry. 2005 May 10;44(18):7035-47. doi: 10.1021/bi050226k.
Retinol dehydrogenase 12 (RDH12) is a novel member of the short-chain dehydrogenase/reductase superfamily of proteins that was recently linked to Leber's congenital amaurosis 3 (LCA). We report the first biochemical characterization of purified human RDH12 and analysis of its expression in human tissues. RDH12 exhibits approximately 2000-fold lower K(m) values for NADP(+) and NADPH than for NAD(+) and NADH and recognizes both retinoids and lipid peroxidation products (C(9) aldehydes) as substrates. The k(cat) values of RDH12 for retinaldehydes and C(9) aldehydes are similar, but the K(m) values are, in general, lower for retinoids. The enzyme exhibits the highest catalytic efficiency for all-trans-retinal (k(cat)/K(m) approximately 900 min(-)(1) microM(-)(1)), followed by 11-cis-retinal (450 min(-)(1) mM(-)(1)) and 9-cis-retinal (100 min(-)(1) mM(-)(1)). Analysis of RDH12 activity toward retinoids in the presence of cellular retinol-binding protein (CRBP) type I or cellular retinaldehyde-binding protein (CRALBP) suggests that RDH12 utilizes the unbound forms of all-trans- and 11-cis-retinoids. As a result, the widely expressed CRBPI, which binds all-trans-retinol with much higher affinity than all-trans-retinaldehyde, restricts the oxidation of all-trans-retinol by RDH12, but has little effect on the reduction of all-trans-retinaldehyde, and CRALBP inhibits the reduction of 11-cis-retinal stronger than the oxidation of 11-cis-retinol, in accord with its higher affinity for 11-cis-retinal. Together, the tissue distribution of RDH12 and its catalytic properties suggest that, in most tissues, RDH12 primarily contributes to the reduction of all-trans-retinaldehyde; however, at saturating concentrations of peroxidic aldehydes in the cells undergoing oxidative stress, for example, photoreceptors, RDH12 might also play a role in detoxification of lipid peroxidation products.
视黄醇脱氢酶12(RDH12)是短链脱氢酶/还原酶超家族蛋白质中的一个新成员,最近被发现与莱伯先天性黑矇3型(LCA)有关。我们报告了纯化的人RDH12的首次生化特性及其在人体组织中的表达分析。RDH12对NADP(+)和NADPH的K(m)值比对NAD(+)和NADH的K(m)值低约2000倍,并将类视黄醇和脂质过氧化产物(C(9)醛)都识别为底物。RDH12对视网膜醛和C(9)醛的k(cat)值相似,但一般来说,类视黄醇的K(m)值更低。该酶对全反式视黄醛的催化效率最高(k(cat)/K(m)约为900 min(-)(1) microM(-)(1)),其次是11-顺式视黄醛(450 min(-)(1) mM(-)(1))和9-顺式视黄醛(100 min(-)(1) mM(-)(1))。在存在I型细胞视黄醇结合蛋白(CRBP)或细胞视网膜醛结合蛋白(CRALBP)的情况下,对RDH12对类视黄醇的活性分析表明,RDH12利用全反式和11-顺式视黄醇的未结合形式。因此,广泛表达的CRBPI与全反式视黄醇的结合亲和力远高于全反式视黄醛,它限制了RDH12对全反式视黄醇的氧化,但对全反式视黄醛的还原影响很小,并且CRALBP对11-顺式视黄醛还原的抑制作用比对11-顺式视黄醇氧化的抑制作用更强,这与其对11-顺式视黄醛的更高亲和力一致。总之,RDH12的组织分布及其催化特性表明,在大多数组织中,RDH12主要有助于全反式视黄醛的还原;然而,在例如光感受器等遭受氧化应激的细胞中,当过氧化物醛达到饱和浓度时,RDH12也可能在脂质过氧化产物的解毒中发挥作用。